Wilson K
Clin Pharmacokinet. 1984 May-Jun;9(3):189-202. doi: 10.2165/00003088-198409030-00001.
Sex-related differences in the disposition of some analgesics, anxiolytics and hypnotics have recently been reported. With certain benzodiazepines, sex has been shown to be a more important determinant of variability in drug disposition than age, while with other benzodiazepines an age-related decline in clearance was more pronounced in men than women. In young healthy adults these sex-related differences in drug disposition were related to the phase of the menstrual cycle, oral contraceptive steroid administration, and variations in plasma concentrations of albumin, alpha 1-acid glycoprotein, free fatty acids and sex hormones. While none of the sex-related differences so far reported necessitates the modification of a therapeutic dosage regimen, it is prudent that future protocols for pharmacokinetic studies should regard age, sex, the menstrual cycle and oral contraceptive steroids as potential sources of variability.
最近有报道称,某些镇痛药、抗焦虑药和催眠药在体内处置方面存在性别差异。对于某些苯二氮䓬类药物,性别已被证明是药物处置变异性比年龄更重要的决定因素,而对于其他苯二氮䓬类药物,男性清除率随年龄的下降比女性更明显。在年轻健康成年人中,这些药物处置方面的性别差异与月经周期阶段、口服避孕药类固醇的使用以及白蛋白、α1-酸性糖蛋白、游离脂肪酸和性激素血浆浓度的变化有关。虽然迄今为止报道的性别差异均无需修改治疗剂量方案,但未来的药代动力学研究方案应谨慎地将年龄、性别、月经周期和口服避孕药类固醇视为潜在的变异性来源。